Navigation Links
PHC Announces 19.2% Increase in Fiscal 2011 First Quarter Revenues
Date:11/10/2010

$

14,233,822

$

11,767,668Contract support services837,598879,760Total revenues15,071,42012,647,428Operating expenses:Patient care expenses7,023,7226,438,563Cost of contract support services707,775727,477Provision for doubtful accounts1,003,462472,973Administrative expenses 5,100,0694,652,517Total operating expenses13,835,02812,291,530Income from operations1,236,392355,898Other income (expense):Interest income40,59432,374Other income38,98849,356Interest expense (80,332)(80,593)Total other income (expense), net(750)1,137Income before provision for income taxes1,235,642357,035Provision for income taxes 557,027133,431Net Income

$

678,615

$

223,604Basic net income per common share

$

0.03

$

0.01Basic weighted average number of shares outstanding19,532,09519,997,549Diluted net income per common share

$

0.03

$

0.01Diluted weighted average number of shares outstanding19,603,13820,141,989
'/>"/>

SOURCE PHC, Inc., d/b/a Pioneer Behavioral Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014  Tasly Pharmaceuticals, Inc., the world,s ... announced today the launch of Deepure. ... address men and women concerned with supporting their ... old age while helping keep their health care ... and herb-based formulas, namely, ProHeart PLUS, ImmunoPower PLUS, ...
(Date:9/30/2014)...  Decision Resources Group finds that the markets for ... , Russia , India ... will see robust expansion as these economies expand and ... Although revenues will be somewhat impeded by poor distribution ... times and demand for low-cost products, the market will ...
(Date:9/30/2014)... , Sept. 30, 2014   Easy Breathe ... destination , today announced that it now offers the ... AirSense CPAPs are the first sleep apnea therapy devices ... simple and easy to track and share real-time data ... effectiveness of their CPAP therapy.  In addition, the internal ...
Breaking Medicine Technology:Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4
... - Abraxis BioScience,Inc. (NASDAQ:ABBI), an integrated, ... pre-clinical studies that,provide evidence for chemotherapy ... (ABRAXANE(R) for Injectable,Suspension (paclitaxel protein-bound particles ... drugs like,bevacizumab (Avastin(R)) at the 98th ...
... LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abraxis ... results from two pre-clinical studies that,support the ... rich in,cysteine) expression in cancer and Abraxis' ... Association for Cancer Research (AACR) Annual Meeting ...
Cached Medicine Technology:Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 2Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 3Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 4Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 5Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 2Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 3Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 4Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 5
(Date:9/30/2014)... NV (PRWEB) September 30, 2014 Fat ... nutrition specialist and best-selling author Mike Geary that is helping ... transform their body into a fat-burning machine in less than ... an investigative review. , “In our culture that is ... be hard to decipher what is really fact and fiction ...
(Date:9/30/2014)... CA (PRWEB) September 30, 2014 ... providers in Turkey has gone up more than 79 ... The medical tourism company also reported total revenue tripled ... 2012. , The company’s professional strategy has allowed them ... — ultimately designed for patient comfort and privacy — ...
(Date:9/30/2014)... Ohio (PRWEB) September 30, 2014 ... new viral strains emerging every day, it’s a ... system. The EnviroShield system is an electro-static ... allows applications to surface normally missed with spray-on ... spray nozzle that adds an electrostatic negative charge ...
(Date:9/30/2014)... Dr. Karl R.O.S. Johnson, DC, has developed ... care that is dramatically improving the health and lives ... & Nutrition—applies a proprietary, multi-dimensional approach that goes beyond ... of inflammation, neurology of the joint and neurology of ... brain to the spine, to the legs, knees and ...
(Date:9/30/2014)... (HealthDay News) -- Medicare should cover low-dose computed tomography ... the disease, a coalition of more than 60 patient ... the Lung Cancer Alliance, the Society of Thoracic Surgeons, ... and the American Society of Clinical Oncology, made its ... Centers for Medicare & Medicaid Services (CMS). Such ...
Breaking Medicine News(10 mins):Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:Columbus Janitorial Company Announces New Disinfecting System for your workplace 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2
... , , ... BZ and APAR < GO >; Reuters: AMIL3.SA), the largest ... released on,November 19, 2009 and December 2, 2009, informs its ... Public Offer defined below,were started today, having as Applicant its ...
... Dec. 9 AdCare Health Systems, Inc. (NYSE AMEX: ... and management company, today reported that it completed a private ... million in cash to fund the Company,s growth initiatives, which ... as well as new management contracts. , "We are pleased ...
... Patients who experience dermatologic toxic effects from epidermal growth ... skin and nail infections, according to a new study ... the National Cancer Institute . This new class ... cancers including lung, pancreatic, breast, head and neck, and ...
... record amounts of money for such efforts , WEDNESDAY, ... tobacco prevention programs by more than 15 percent in ... of money from tobacco taxes and from the 1998 ... "Fully funded tobacco prevention and cessation programs stop addiction ...
... ... non-biased assistance to Medicare eligibles in finding the right Medicare plan for their particular ... ... officially beginning on November 15th. 6,000 people become eligible for Medicare everyday in the ...
... , , , DETROIT, Dec. 9 ... of the 26th Annual Awards. , On September 29 at ... 26th Annual Awards Ceremony. The theme for this ... , These awards were presented to corporations and individuals who ...
Cached Medicine News:Health News:AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives 2Health News:AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives 3Health News:States Slash Funding for Tobacco Prevention Programs 2Health News:States Slash Funding for Tobacco Prevention Programs 3Health News:www.RightMedicare.com Launches to Offer Non-Biased Medicare Enrollment Assistance 2Health News:Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: